Recent Updates
Recently added Catalysts
JNJ

Johnson & Johnson Announces Third-Quarter 2011 Quarterly Dividend Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the third quarter of 2011 of $0.57 per...

Key Takeaway: NEW BRUNSWICK, N.J. , July 18, 2011 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ ) today announced that its Board of Directors has declared a cash dividend for the third quarter of 2011 of $0.57 per share on the company's common stock. The dividend is payable on Sept. 13, 2011 ,

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.6%
average across 15 past catalysts
Lead asset
Canagliflozin
Phase 3 · Diabetes Mellitus, Type 2

Full Press Release Details

NEW BRUNSWICK, N.J. , July 18, 2011 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ ) today announced that its Board of Directors has declared a cash dividend for the third quarter of 2011 of $0.57 per share on the company's common stock. The dividend is payable on Sept. 13, 2011 , to shareholders of record at the close of business on Aug. 30, 2011 . The ex-dividend date is Aug. 26, 2011 .
About Johnson & Johnson
Caring for the world, one person at a time…inspires and unites the people of Johnson & Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Our approximately 116,000 employees at more than 250 Johnson & Johnson companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.
Last updated: Jul 18, 2011